MedPath

Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio as Predictors for Adverse Events in EVAR

Completed
Conditions
Inflammation in EVAR
Interventions
Other: NLR
Registration Number
NCT04254211
Lead Sponsor
University of Thessaly
Brief Summary

This study investigated the association of chronic inflammatory markers with the clinical outcome after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm.

Detailed Description

The study included 230 consecutive AAA patients, treated electively by EVAR from March 2016 to February 2019. The values of simple inflammatory markers,neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), were measured pre- and postoperatively.Adverse events included any major adverse cardiovascular events (MACE), acute kidney injury and death from any cause.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
230
Inclusion Criteria
  • AAA
  • Elective
  • EVAR
Exclusion Criteria
  • Emergency
  • Open surgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
EVARNLRPatinets with AAA, treated electively by EVAR. The values of simple inflammatory markers,neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), were measured pre- and postoperatively. Adverse events included any major adverse cardiovascular events (MACE), acute kidney injury and death from any cause
Primary Outcome Measures
NameTimeMethod
PLR acute kidney injury (AKI)Day 4 postopertively

PLR indicator for acute kidney injury (AKI)

PLR major cardiovascular events (MACE)Day 4 postopertively

PLR indicator for major cardiovascular events (MACE)

NLR acute kidney injury (AKI)Day 4 postopertively

NLR indicator for acute kidney injury (AKI)

NLR deathDay 4 postopertively

NLR indicator for death

NLR major cardiovascular events (MACE)Day 4 postopertively

NLR indicator for major cardiovascular events (MACE)

PLR deathDay 4 postopertively

PLR indicator for death

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Univeristy of Thessaly

🇬🇷

Larissa, Thessaly, Greece

© Copyright 2025. All Rights Reserved by MedPath